139P Multimodal prognosis modeling of advanced NSCLC treated with first-line immunochemotherapy: Integrating genomic and microenvironmental data
Yu Hu(Wuhan Union Hospital), Jianguo Hu(Chengdu University of Traditional Chinese Medicine), Haifeng Gao(China Rehabilitation Research Center), Xiao Li(Zhejiang Provincial People's Hospital), Shengchun Liu(The Affiliated Yongchuan Hospital of Chongqing Medical University), Xin Liu(Harbin Normal University), Fan Zhang(Southwest Medical University), Zheng Liu(Wuhan University), Jingjing Wang(Ningxia University), Jing Ma(Yangtze University), Hui Wang(Beijing University of Chinese Medicine), Jun Wen(Chinese University of Hong Kong), Yan Han(Chinese PLA General Hospital), Qin Hu(Yunnan University), Bo Yang(Chinese Academy of Medical Sciences & Peking Union Medical College), Huan Tao(Chinese PLA General Hospital), Wenli Xiao(Chinese PLA General Hospital), L. Wang(Northwest A&F University), Dingzhi Huang(Tianjin Medical University Cancer Institute and Hospital)
Cited by 0
Related Papers
The genomic sequence of the Chinese hamster ovary (CHO)-K1 cell line
|Nature Biotechnology|2011|793
A Human Pluripotent Stem Cell-based Platform to Study SARS-CoV-2 Tropism and Model Virus Infection in Human Cells and Organoids
|Cell stem cell|2020|676
Maize HapMap2 identifies extant variation from a genome in flux
|Nature Genetics|2012|654